Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy

Diabetes Research and Clinical Practice

Volumn 32, Issue 1-2, 1996, Pages 45-53

  Simó, Rafel ^a   Masmiquel, Lluis ^a   García Pascual, LLuis ^a   Burgos, Rosa ^a   Mateo, Carles ^a   Segura, Rosa Maria ^a   Mesa, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Diabetes mellitus; Diabetic microangiopathy; Laminin

Indexed keywords

ALBUMIN; ALCOHOL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FLUORESCEIN SODIUM; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LAMININ; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; ORAL DRUG ADMINISTRATION; PROLIFERATIVE RETINOPATHY; PROTEINURIA; RADIOIMMUNOASSAY; TOBACCO;

EID: 0029945057     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01220-X     Document Type: Article

References (38)

1. Studies of muscle capillary basement membranes in normal subjects, diabetic and pre-diabetic patients
2. Laminin — a glycoprotein from basement membranes
3. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy
4. Effect of age and diabetes on type IV collagen and laminin in human kidney cortex
5. Pathobiochemical aspects of diabetic nephropathy
6. Increased steady state levels of laminin B1 mRNA in kidneys of long term streptozotocin diabetic rats: no effect of an aldose reductase inhibitor
7. Changes in glomerular membrane components in diabetic nephropathy
8. Aminoguanidine treatment normalizes increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats
9. Altered mRNA expression of glomerular basement membrane components in streptozotocin (STZ) diabetic rats
10. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions
11. Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes
12. Radioimmunoassay of laminin in serum and its application to cancer patients
13. One step sandwich enzyme immunoassay for human laminin using monoclonal antibodies
14. Serum concentrations of laminin in type I diabetic patients with and without microangiopathy
15. 1 in sera of patients with diabetes mellitus
16. Dosage sérique du fragment P1 de la lamininine humaine
17. Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy
18. 1 in diabetics with advanced nephropathy
19. Plasma laminin may reflect the severity of microangiopathy in non-uraemic patients with type I (insulin-dependent) diabetes
20. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes
21. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
22. Predicting diabetic nephropathy in insulin-dependent patients
23. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
24. Determination of laminin in serum by a competitive radioimmunoassay directed against the pepsin-resistant fragment P1
25. Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases
26. Serum concentration of laminin and course of the disease in patients with various malignancies
27. Serum laminin P1 fragment concentration in renal diseases
28. Aging changes in the retinal capillary bed of the rat
29. 1 fragment concentrations in alcoholic liver disease and primary biliary cirrhosis
30. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis and alcohol intake
31. 1 in patients with and without microangiopathies
32. 1 in body fluids of pregnant women, patients with gynaecological cancer and controls
33. Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells
34. Estimation of the production rates of serum aminoterminal propeptide of type III procollagen and laminin in human fibrotic liver
35. Increased expression of basement membrane components in human endothelial cells cultured in high glucose
36. Concordant upregulation of extracellular matrix components and their receptors by high glucose in human endothelial cells
37. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin and type IV collagen association
38. Laminin alterations after in vitro non enzymatic glycosylation